Oct. 18 (Bloomberg) -- Marc Beer, chief executive officer of Aegerion Pharmaceuticals Inc., talks about the company's lomitapide drug to treat the most life-threatening forms of high cholesterol. A U.S. Food and Drug Administration panel supported the use of the drug.
Beer speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
58:02 - Oil is gaining ahead of a U.S. Government report on crude supplies. Analysts surveyed say supplies probably fell last week. Bloomberg’s Aaron Clark reports on “Trending Business.”
Iron Ore Rebound May Spread Across Commodities
CapitaLand Profit Rises on Climbing Rents
Japan Stocks Attractive on Buyback Prospects
Please upgrade your Browser
Your browser is out-of-date. Please download one of these excellent browsers: